OBJECTIVE: To examine whether genetic variations within the surfactant protein A2 (SP-A2) gene are associated with respiratory syncytial virus (RSV) disease severity in infected children. STUDY DESIGN: Naturally infected children aged < or =24 months were prospectively enrolled in 3 RSV seasons. SP-A2 genotyping was performed. Independent clinical predictors of disease severity were analyzed. The association of SP-A2 genetic diversity and disease severity was tested by using multivariate logistic regression models and 4 levels of disease gradation as outcome measures. RESULTS: Homozygosity of the 1A(0) allele was protective against hospitalization (odds ratio [OR] = 0.15, P = .0010). This remained significant in African American patients (OR = 0.24, P = .042) and Caucasian patients (OR = 0.05, P = .021) after adjustment for other co-variates. Hospitalized children with the 1A(2) allele demonstrated significant protection from severe disease with univariate analyses, but only a trend for protection with multivariate analyses. Patients homozygous or heterozygous for an asparagine at amino acid position 9 were twice or more likely to need intensive care unit admission (OR = 2.15, P = .022), require intubation (OR = 3.04, P = .005), and have a hospitalization lasting > or =4 days (OR = 1.89, P = .02) compared with children homozygous for a threonine at this position. CONCLUSIONS: SP-A2 polymorphisms are associated with the severity of RSV infection in infants. Copyright 2010 Mosby, Inc. All rights reserved.
OBJECTIVE: To examine whether genetic variations within the surfactant protein A2 (SP-A2) gene are associated with respiratory syncytial virus (RSV) disease severity in infected children. STUDY DESIGN: Naturally infected children aged < or =24 months were prospectively enrolled in 3 RSV seasons. SP-A2 genotyping was performed. Independent clinical predictors of disease severity were analyzed. The association of SP-A2 genetic diversity and disease severity was tested by using multivariate logistic regression models and 4 levels of disease gradation as outcome measures. RESULTS: Homozygosity of the 1A(0) allele was protective against hospitalization (odds ratio [OR] = 0.15, P = .0010). This remained significant in African American patients (OR = 0.24, P = .042) and Caucasian patients (OR = 0.05, P = .021) after adjustment for other co-variates. Hospitalized children with the 1A(2) allele demonstrated significant protection from severe disease with univariate analyses, but only a trend for protection with multivariate analyses. Patients homozygous or heterozygous for an asparagine at amino acid position 9 were twice or more likely to need intensive care unit admission (OR = 2.15, P = .022), require intubation (OR = 3.04, P = .005), and have a hospitalization lasting > or =4 days (OR = 1.89, P = .02) compared with children homozygous for a threonine at this position. CONCLUSIONS:SP-A2 polymorphisms are associated with the severity of RSV infection in infants. Copyright 2010 Mosby, Inc. All rights reserved.
Authors: Chadi M El Saleeby; Andy J Bush; Lisa M Harrison; Jody A Aitken; John P Devincenzo Journal: J Infect Dis Date: 2011-10-01 Impact factor: 5.226
Authors: Ying Wang; Dennis R Voelker; Njira L Lugogo; Guirong Wang; Joanna Floros; Jennifer L Ingram; Hong Wei Chu; Tony D Church; Pitchaimani Kandasamy; Daniel Fertel; Jo Rae Wright; Monica Kraft Journal: Am J Physiol Lung Cell Mol Physiol Date: 2011-07-22 Impact factor: 5.464
Authors: Julie G Ledford; Dennis R Voelker; Kenneth J Addison; Ying Wang; Vinayak S Nikam; Simone Degan; Pitachaimani Kandasamy; Sasipa Tanyaratsrisakul; Bernard M Fischer; Monica Kraft; John W Hollingsworth Journal: J Immunol Date: 2015-05-08 Impact factor: 5.422